Compare BCRX & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCRX | NEOG |
|---|---|---|
| Founded | 1986 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 1995 | 1995 |
| Metric | BCRX | NEOG |
|---|---|---|
| Price | $9.81 | $10.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $20.82 | $10.67 |
| AVG Volume (30 Days) | ★ 5.9M | 2.1M |
| Earning Date | 05-04-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | N/A |
| EPS | ★ 1.21 | 0.09 |
| Revenue | $25,186,000.00 | ★ $894,661,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.55 | $1.67 |
| P/E Ratio | ★ $8.07 | $115.17 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $4.32 |
| 52 Week High | $11.31 | $11.43 |
| Indicator | BCRX | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 64.16 | 62.33 |
| Support Level | $7.85 | $4.78 |
| Resistance Level | $10.32 | $11.43 |
| Average True Range (ATR) | 0.56 | 0.43 |
| MACD | -0.05 | 0.17 |
| Stochastic Oscillator | 63.99 | 84.35 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.